SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-22-265387
Filing Date
2022-10-19
Accepted
2022-10-19 17:29:58
Documents
2
Group Members
CANAAN PARTNERS XI LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d389588dsc13da.htm SC 13D/A 48547
2 EX-99.1 d389588dex991.htm EX-99.1 4383
  Complete submission text file 0001193125-22-265387.txt   54606
Mailing Address 285 RIVERSIDE AVENUE SUITE 250 WESTPORT CT 06880
Business Address 285 RIVERSIDE AVENUE SUITE 250 WESTPORT CT 06880 203-855-0400
Canaan XI L.P. (Filed by) CIK: 0001712417 (see all company filings)

IRS No.: 981377917 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94080-1930
Business Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94080-1930 650 484-0899
Day One Biopharmaceuticals, Inc. (Subject) CIK: 0001845337 (see all company filings)

IRS No.: 832415215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92582 | Film No.: 221319317
SIC: 2834 Pharmaceutical Preparations